Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 49.10
+0.40 (0.82%)
May 15, 2026, 10:47 AM CET
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 218.1 million as of May 15, 2026.
Market Cap
218.10M
Enterprise Value
44.04M
Revenue
28.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.10
Market Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 218.10M, an increase of 17.00%. That is a compound annual growth rate of 34.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 218.10M | -0.81% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.67B |
| Thor Medical ASA | 1.62B |
| ArcticZymes Technologies ASA | 1.06B |
| Nykode Therapeutics AS | 1.03B |
| Lytix Biopharma ASA | 815.14M |
| Zelluna ASA | 556.92M |
| SoftOx Solutions AS | 298.98M |
| EXACT Therapeutics AS | 80.98M |